NCT02976415 (CardiO Cycle) is a NA clinical trial of In-Bed Cycling in Cardiac Disease, sponsored by Hamilton Health Sciences Corporation.

Who is sponsoring NCT02976415?

NCT02976415 is sponsored by Hamilton Health Sciences Corporation.

What drugs are being tested in NCT02976415?

Interventions in NCT02976415: In-Bed Cycling.

What condition does NCT02976415 study?

NCT02976415 studies Cardiac Disease, Critical Illness, Critical Illness Polyneuropathy, Critical Illness Myopathy, Thoracic Surgery.

Is NCT02976415 still recruiting?

NCT02976415 is currently completed. Last updated 31 July 2020.

Last reviewed 2020-07-31 · How we verify

NCT02976415: CardiO Cycle

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

In-Bed Cycling in ICU Patients Post Cardiac Surgery

Completed NA Last updated 31 July 2020

What this trial tests

NA trial testing In-Bed Cycling in Cardiac Disease in 23 participants. Completed in 29 March 2019.

Timeline

28 August 2017

Primary endpoint
29 March 2019

29 March 2019

Quick facts

Lead sponsor	Hamilton Health Sciences Corporation
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	23
Start date	28 August 2017
Primary completion	29 March 2019
Estimated completion	29 March 2019
Sites	1 location across Canada

Drugs / interventions tested

In-Bed Cycling

Conditions studied

Cardiac Disease — all drugs for Cardiac Disease →
Critical Illness — all drugs for Critical Illness →
Critical Illness Polyneuropathy — all drugs for Critical Illness Polyneuropathy →
Critical Illness Myopathy — all drugs for Critical Illness Myopathy →

Sponsor

Hamilton Health Sciences Corporation — full company profile →

Who can join

18 and older, any sex, with Cardiac Disease or Critical Illness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine if in-bed cycling is safe and feasible in critically-ill patients after open heart surgery. The investigators hypothesize that in-bed cycling can be safely used with this population and that it is feasible to use in a fast-paced cardiac intensive care unit.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

CardiO Cycle: a pilot feasibility study of in-bed cycling in critically ill patients post cardiac surgery.
Newman ANL, Kho ME, Harris JE, Zamir N, et al · · 2021 · cited 5× · PMID 33407923 · DOI 10.1186/s40814-020-00760-5

Verify or expand the search:

Other recruiting trials for Cardiac Disease

Currently open trials in the same condition.

NCT07532174 — Efferon LPS Hemoadsorption in Cardiac Surgery Patients · NA · recruiting
NCT06294119 — Multivariate Approach to the Numerical Assessment of Cortical - Autonomic - VAscular Dynamic Interplay · NA · recruiting
NCT07274436 — The Clinical Value of Deep Learning-Based Reconstruction Techniques in Cardiac MRI Scanning · recruiting
NCT07217392 — Left Bundle Branch Area Pacing (LBBAP) PMCF Study · NA · recruiting
NCT05877755 — Validation of Multi-contrast, High-resolution Cardiac Magnetic Resonance Imaging · NA · recruiting

Other Hamilton Health Sciences Corporation trials

Trials by the same sponsor.

NCT06567808 — Prevention of Infections in Cardiac Surgery (PICS): a Cluster-randomized Factorial Cross-over Trial · Phase 4 · not yet recruiting
NCT07118696 — Evaluating a Shorter, Rifampicin-Based Treatment for People With Less Severe Tuberculosis Disease · Phase 3 · not yet recruiting
NCT07027436 — Radiation Therapy Followed by Durvalumab (MEDI4736) and Tremelimumab And Surgery Versus Radiation Therapy Followed by Su · Phase 3 · not yet recruiting
NCT06908694 — Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy · Phase 4 · recruiting
NCT06836024 — A Trial of Actazin Versus PEG 3350 for Maintenance Therapy in Children With Constipation · Phase 2, PHASE3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02976415 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hamilton Health Sciences Corporation
Last refreshed: 31 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02976415.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing